PVA

PSIVIDA CORP. - Announcements

0.00%

$2.99

Currently unlisted.

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

PVA	Appendix 3B		02/05/14	2.61MB	Share
PVA	pSivida Reports Australia/New Zealand Distribution Agreement	PRICE SENSITIVE	29/04/14	267.26KB	Share
PVA	Selected to Present at 2014 Opthalmology Innovation Summit		24/04/14	96.42KB	Share
PVA	PVA announces September 26, 2014 PDUFA date		15/04/14	88.09KB	Share
PVA	Appendix 3B		03/04/14	2.6MB	Share
PVA	pSivida CEO presents at upcoming conferences		02/04/14	886.19KB	Share
PVA	pSivida announces resubmission of NDA for Iluvien	PRICE SENSITIVE	28/03/14	171.32KB	Share
PVA	Prospectus Supplement	PRICE SENSITIVE	18/03/14	171.32KB	Share
PVA	Form 8-K		14/03/14	203.3KB	Share
PVA	pSivida announces a US$7m investment by RA Capital	PRICE SENSITIVE	14/03/14	173.52KB	Share
PVA	Appendix 3B		05/03/14	2.51MB	Share
PVA	Form 10-Q December 2013	PRICE SENSITIVE	13/02/14	433.53KB	Share
PVA	pSivida's Iluvien for DME accepted by NHS in Scotland	PRICE SENSITIVE	11/02/14	172.13KB	Share
PVA	pSivida Corp. Reports Second Qtr 2014 Financial Results	PRICE SENSITIVE	10/02/14	117.59KB	Share
PVA	pSivida CEO to present at the BioCEO Conference in NY		07/02/14	176.92KB	Share
PVA	Appendix 3B		04/02/14	2.53MB	Share
PVA	Q2 2014 Financial Results Release Date and Conference Call		31/01/14	139.15KB	Share
PVA	Corporate Governance Report		30/01/14	200.93KB	Share
PVA	Form 8-K - Hopper		22/01/14	34.21KB	Share
PVA	Appendix 3Z		21/01/14	402.23KB	Share
PVA	First orders for Iluven shipped to the UK for NHS hospitals	PRICE SENSITIVE	14/01/14	187.24KB	Share
PVA	Appendix 3B		08/01/14	2.57MB	Share
PVA	Form 8-K		03/01/14	323.89KB	Share
PVA	pSivida Prospectus Supplement		03/01/14	251.42KB	Share
PVA	pSivida Form 8-K - AGM Results		24/12/13	37.9KB	Share
PVA	Appendix 3Y - Savas		23/12/13	698.08KB	Share
PVA	Appendix 3Y - Rogers		23/12/13	655.1KB	Share
PVA	Appendix 3Y - Mazzo		23/12/13	660.47KB	Share
PVA	Appendix 3Y - Hopper		23/12/13	669.79KB	Share
PVA	Appendix 3Y - Godshall		23/12/13	587.96KB	Share
PVA	Appendix 3Y - Ashton		23/12/13	681.12KB	Share
PVA	pSivida reports labeling discussions with FDA for Iluvien	PRICE SENSITIVE	19/12/13	194.5KB	Share
PVA	pSivida Executives to Present at Two Conferences in December		05/12/13	93.96KB	Share
PVA	Appendix 3B		03/12/13	2.57MB	Share
PVA	pSivida reports that Iluvien to be funded by the UK's NHS	PRICE SENSITIVE	03/12/13	222.06KB	Share
PVA	Form 10-Q		14/11/13	477.9KB	Share
PVA	pSivida reports first quarter FY 2014 financial results	PRICE SENSITIVE	13/11/13	165.62KB	Share
PVA	pSivida Q1 FY2014 Financials Release Date & Conference Call		06/11/13	250.14KB	Share
PVA	Appendix 3B		05/11/13	2.52MB	Share
PVA	Notice of Annual General Meeting/Proxy Form		29/10/13	310.58KB	Share
PVA	pSivida reports complete response letter from the FDA	PRICE SENSITIVE	21/10/13	183.9KB	Share
PVA	Trading Halt Request		18/10/13	415.2KB	Share
PVA	Trading Halt	PRICE SENSITIVE	18/10/13	100.23KB	Share
PVA	Appendix 3B		04/10/13	2.51MB	Share
PVA	UK's NICE recommends pSivida's Illuvien for reimbursement	PRICE SENSITIVE	01/10/13	222.55KB	Share
PVA	pSivida to present at biosimilars & biobetters conference		30/09/13	100.52KB	Share
PVA	Form 10-K	PRICE SENSITIVE	30/09/13	503.88KB	Share
PVA	pSivida reports fourth qtr and fiscal 2013 financial results	PRICE SENSITIVE	26/09/13	235.89KB	Share
PVA	pSivida fourth qtr and fiscal 2013 financials release date		19/09/13	216.71KB	Share
PVA	pSivida to Present At Two Investment Conferences in Sept.		05/09/13	193.02KB	Share
PVA	Appendix 3B		04/09/13	2.53MB	Share
PVA	Appendix 3B		13/08/13	2.6MB	Share
PVA	Form 4 - Ross		06/08/13	414.8KB	Share
PVA	Form 4 - Freedman		06/08/13	510.21KB	Share
PVA	pSivida CEO to speak at International Symposium in Texas, US		30/07/13	91.33KB	Share
PVA	Positive opinion issued for Iluvien reimbursment in France	PRICE SENSITIVE	25/07/13	217.59KB	Share
PVA	pSivida capital raising prospectus July 2013	PRICE SENSITIVE	23/07/13	298.84KB	Share
PVA	pSivida announces pricing of $10.8m offering	PRICE SENSITIVE	22/07/13	62.27KB	Share
PVA	Trading Halt	PRICE SENSITIVE	19/07/13	74.54KB	Share
PVA	pSivida planned capital raising	PRICE SENSITIVE	19/07/13	103.62KB	Share
PVA	pSivida interim data on uveitis investigator sponsored study	PRICE SENSITIVE	12/07/13	148.37KB	Share
PVA	Appendix 3B		02/07/13	1.6MB	Share
PVA	Initiation of Phase III Clinical Trial in Posterior Uveitis	PRICE SENSITIVE	02/07/13	166.25KB	Share
PVA	UK's NICE issues draft guidance recommending Iluvien for DME		17/06/13	221.16KB	Share
PVA	Appendix 3B		04/06/13	2.53MB	Share
PVA	New tech evaluation agreement with global pharma	PRICE SENSITIVE	30/05/13	195.95KB	Share
PVA	Form 10-Q		15/05/13	226.98KB	Share
PVA	pSivida Corp. third quarter fiscal year 2013 results	PRICE SENSITIVE	14/05/13	227.17KB	Share
PVA	pSivida's Iluvien launches in Germany- first patient treated	PRICE SENSITIVE	08/05/13	166.65KB	Share
PVA	pSivida announces third qtr financial results release date		07/05/13	214.03KB	Share
PVA	Appendix 3B		02/05/13	2.52MB	Share
PVA	pSivida Announces New ILUVIEN PDUFA Date of October 17, 2013	PRICE SENSITIVE	02/05/13	211.86KB	Share
PVA	pSivida reports that Iluvien is now available in the UK	PRICE SENSITIVE	30/04/13	66.27KB	Share
PVA	pSivida launches new online corporate communications channel		11/04/13	92.31KB	Share
PVA	pSivida Reports Updates on Iluvien FDA Resubmission	PRICE SENSITIVE	25/03/13	60.58KB	Share
PVA	pSivida to present at the 5th Ocular Diseases and Drug Conf.		21/03/13	224.62KB	Share
PVA	Appendix 3B		04/03/13	1.61MB	Share
PVA	Half Yearly Report and Accounts	PRICE SENSITIVE	14/02/13	437.24KB	Share
PVA	Form 10-Q		11/02/13	226.3KB	Share
PVA	pSivida reports second quarter fiscal results 2013	PRICE SENSITIVE	07/02/13	179.34KB	Share
PVA	Appendix 3B		05/02/13	1.59MB	Share
PVA	pSivida CEO to present at the BIOCEO Conference in NY		05/02/13	180.88KB	Share
PVA	pSivida announce 2nd Qtr 2013 financial results release date		31/01/13	129.97KB	Share
PVA	Final published guidance from UK's NICE	PRICE SENSITIVE	24/01/13	222.23KB	Share
PVA	Appendix 3B		22/01/13	2.52MB	Share
PVA	Amendment No. 1 to Form S-3 Registarion Statement		18/01/13	187.61KB	Share
PVA	pSivida's Iluvien approved for sale in Spain	PRICE SENSITIVE	18/01/13	199.11KB	Share
PVA	pSivida Corporate Governance Report		15/01/13	199.36KB	Share
PVA	Form S-3		20/12/12	186.33KB	Share
PVA	Form 8K - AGM Results		19/12/12	37KB	Share
PVA	Appendix 3Y		18/12/12	70.76KB	Share
PVA	Appendix 3Y		17/12/12	71KB	Share
PVA	Appendix 3Y		17/12/12	71KB	Share
PVA	Appendix 3Y		17/12/12	70.79KB	Share
PVA	Appendix 3Y		17/12/12	70.74KB	Share
PVA	Appendix 3Y		17/12/12	71.14KB	Share
PVA	Form 4		17/12/12	29.17KB	Share
PVA	Form 4		17/12/12	29.31KB	Share
PVA	Form 4		17/12/12	28.69KB	Share
PVA	Appendix 3Y		17/12/12	71.41KB	Share

PVAAppendix 3B
02/05/14		2.61MB	Share
PVApSivida Reports Australia/New Zealand Distribution Agreement
29/04/14	PRICE SENSITIVE	267.26KB	Share
PVASelected to Present at 2014 Opthalmology Innovation Summit
24/04/14		96.42KB	Share
PVAPVA announces September 26, 2014 PDUFA date
15/04/14		88.09KB	Share
PVAAppendix 3B
03/04/14		2.6MB	Share
PVApSivida CEO presents at upcoming conferences
02/04/14		886.19KB	Share
PVApSivida announces resubmission of NDA for Iluvien
28/03/14	PRICE SENSITIVE	171.32KB	Share
PVAProspectus Supplement
18/03/14	PRICE SENSITIVE	171.32KB	Share
PVAForm 8-K
14/03/14		203.3KB	Share
PVApSivida announces a US$7m investment by RA Capital
14/03/14	PRICE SENSITIVE	173.52KB	Share
PVAAppendix 3B
05/03/14		2.51MB	Share
PVAForm 10-Q December 2013
13/02/14	PRICE SENSITIVE	433.53KB	Share
PVApSivida's Iluvien for DME accepted by NHS in Scotland
11/02/14	PRICE SENSITIVE	172.13KB	Share
PVApSivida Corp. Reports Second Qtr 2014 Financial Results
10/02/14	PRICE SENSITIVE	117.59KB	Share
PVApSivida CEO to present at the BioCEO Conference in NY
07/02/14		176.92KB	Share
PVAAppendix 3B
04/02/14		2.53MB	Share
PVAQ2 2014 Financial Results Release Date and Conference Call
31/01/14		139.15KB	Share
PVACorporate Governance Report
30/01/14		200.93KB	Share
PVAForm 8-K - Hopper
22/01/14		34.21KB	Share
PVAAppendix 3Z
21/01/14		402.23KB	Share
PVAFirst orders for Iluven shipped to the UK for NHS hospitals
14/01/14	PRICE SENSITIVE	187.24KB	Share
PVAAppendix 3B
08/01/14		2.57MB	Share
PVAForm 8-K
03/01/14		323.89KB	Share
PVApSivida Prospectus Supplement
03/01/14		251.42KB	Share
PVApSivida Form 8-K - AGM Results
24/12/13		37.9KB	Share
PVAAppendix 3Y - Savas
23/12/13		698.08KB	Share
PVAAppendix 3Y - Rogers
23/12/13		655.1KB	Share
PVAAppendix 3Y - Mazzo
23/12/13		660.47KB	Share
PVAAppendix 3Y - Hopper
23/12/13		669.79KB	Share
PVAAppendix 3Y - Godshall
23/12/13		587.96KB	Share
PVAAppendix 3Y - Ashton
23/12/13		681.12KB	Share
PVApSivida reports labeling discussions with FDA for Iluvien
19/12/13	PRICE SENSITIVE	194.5KB	Share
PVApSivida Executives to Present at Two Conferences in December
05/12/13		93.96KB	Share
PVAAppendix 3B
03/12/13		2.57MB	Share
PVApSivida reports that Iluvien to be funded by the UK's NHS
03/12/13	PRICE SENSITIVE	222.06KB	Share
PVAForm 10-Q
14/11/13		477.9KB	Share
PVApSivida reports first quarter FY 2014 financial results
13/11/13	PRICE SENSITIVE	165.62KB	Share
PVApSivida Q1 FY2014 Financials Release Date & Conference Call
06/11/13		250.14KB	Share
PVAAppendix 3B
05/11/13		2.52MB	Share
PVANotice of Annual General Meeting/Proxy Form
29/10/13		310.58KB	Share
PVApSivida reports complete response letter from the FDA
21/10/13	PRICE SENSITIVE	183.9KB	Share
PVATrading Halt Request
18/10/13		415.2KB	Share
PVATrading Halt
18/10/13	PRICE SENSITIVE	100.23KB	Share
PVAAppendix 3B
04/10/13		2.51MB	Share
PVAUK's NICE recommends pSivida's Illuvien for reimbursement
01/10/13	PRICE SENSITIVE	222.55KB	Share
PVApSivida to present at biosimilars & biobetters conference
30/09/13		100.52KB	Share
PVAForm 10-K
30/09/13	PRICE SENSITIVE	503.88KB	Share
PVApSivida reports fourth qtr and fiscal 2013 financial results
26/09/13	PRICE SENSITIVE	235.89KB	Share
PVApSivida fourth qtr and fiscal 2013 financials release date
19/09/13		216.71KB	Share
PVApSivida to Present At Two Investment Conferences in Sept.
05/09/13		193.02KB	Share
PVAAppendix 3B
04/09/13		2.53MB	Share
PVAAppendix 3B
13/08/13		2.6MB	Share
PVAForm 4 - Ross
06/08/13		414.8KB	Share
PVAForm 4 - Freedman
06/08/13		510.21KB	Share
PVApSivida CEO to speak at International Symposium in Texas, US
30/07/13		91.33KB	Share
PVAPositive opinion issued for Iluvien reimbursment in France
25/07/13	PRICE SENSITIVE	217.59KB	Share
PVApSivida capital raising prospectus July 2013
23/07/13	PRICE SENSITIVE	298.84KB	Share
PVApSivida announces pricing of $10.8m offering
22/07/13	PRICE SENSITIVE	62.27KB	Share
PVATrading Halt
19/07/13	PRICE SENSITIVE	74.54KB	Share
PVApSivida planned capital raising
19/07/13	PRICE SENSITIVE	103.62KB	Share
PVApSivida interim data on uveitis investigator sponsored study
12/07/13	PRICE SENSITIVE	148.37KB	Share
PVAAppendix 3B
02/07/13		1.6MB	Share
PVAInitiation of Phase III Clinical Trial in Posterior Uveitis
02/07/13	PRICE SENSITIVE	166.25KB	Share
PVAUK's NICE issues draft guidance recommending Iluvien for DME
17/06/13		221.16KB	Share
PVAAppendix 3B
04/06/13		2.53MB	Share
PVANew tech evaluation agreement with global pharma
30/05/13	PRICE SENSITIVE	195.95KB	Share
PVAForm 10-Q
15/05/13		226.98KB	Share
PVApSivida Corp. third quarter fiscal year 2013 results
14/05/13	PRICE SENSITIVE	227.17KB	Share
PVApSivida's Iluvien launches in Germany- first patient treated
08/05/13	PRICE SENSITIVE	166.65KB	Share
PVApSivida announces third qtr financial results release date
07/05/13		214.03KB	Share
PVAAppendix 3B
02/05/13		2.52MB	Share
PVApSivida Announces New ILUVIEN PDUFA Date of October 17, 2013
02/05/13	PRICE SENSITIVE	211.86KB	Share
PVApSivida reports that Iluvien is now available in the UK
30/04/13	PRICE SENSITIVE	66.27KB	Share
PVApSivida launches new online corporate communications channel
11/04/13		92.31KB	Share
PVApSivida Reports Updates on Iluvien FDA Resubmission
25/03/13	PRICE SENSITIVE	60.58KB	Share
PVApSivida to present at the 5th Ocular Diseases and Drug Conf.
21/03/13		224.62KB	Share
PVAAppendix 3B
04/03/13		1.61MB	Share
PVAHalf Yearly Report and Accounts
14/02/13	PRICE SENSITIVE	437.24KB	Share
PVAForm 10-Q
11/02/13		226.3KB	Share
PVApSivida reports second quarter fiscal results 2013
07/02/13	PRICE SENSITIVE	179.34KB	Share
PVAAppendix 3B
05/02/13		1.59MB	Share
PVApSivida CEO to present at the BIOCEO Conference in NY
05/02/13		180.88KB	Share
PVApSivida announce 2nd Qtr 2013 financial results release date
31/01/13		129.97KB	Share
PVAFinal published guidance from UK's NICE
24/01/13	PRICE SENSITIVE	222.23KB	Share
PVAAppendix 3B
22/01/13		2.52MB	Share
PVAAmendment No. 1 to Form S-3 Registarion Statement
18/01/13		187.61KB	Share
PVApSivida's Iluvien approved for sale in Spain
18/01/13	PRICE SENSITIVE	199.11KB	Share
PVApSivida Corporate Governance Report
15/01/13		199.36KB	Share
PVAForm S-3
20/12/12		186.33KB	Share
PVAForm 8K - AGM Results
19/12/12		37KB	Share
PVAAppendix 3Y
18/12/12		70.76KB	Share
PVAAppendix 3Y
17/12/12		71KB	Share
PVAAppendix 3Y
17/12/12		71KB	Share
PVAAppendix 3Y
17/12/12		70.79KB	Share
PVAAppendix 3Y
17/12/12		70.74KB	Share
PVAAppendix 3Y
17/12/12		71.14KB	Share
PVAForm 4
17/12/12		29.17KB	Share
PVAForm 4
17/12/12		29.31KB	Share
PVAForm 4
17/12/12		28.69KB	Share
PVAAppendix 3Y
17/12/12		71.41KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

PSIVIDA CORP. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available